Symptomdx.

Get Started

New Tremor and Involuntary MovementsAPPROACH

NEUROLOGIC · 19 SECTIONS

⚲

582 items

☷ Legend

⚲

Resuscitation and Universal Approaches9▾

Chest and Cardiovascular12▾

Respiratory11▾

Abdominal and Gastrointestinal24▾

Renal and Urinary7▾

Neurologic11▾

Transient Neurologic Deficits Acute Aphasia And Speech Disturbance Acute Confusion And Delirium Postictal State And Seizure Recurrence Concern Seizure Acute Vision Loss New Tremor And Involuntary Movements Headache Vertigo Acute Weakness Or Numbness Gait Instability And Ataxia

Back and Neck8▾

Women's Health, Pregnancy, and GU11▾

Infectious Disease and Fever Syndromes11▾

Allergy and Dermatology7▾

Musculoskeletal and Extremities14▾

Trauma and Wounds14▾

ENT, Eye, Dental10▾

Endocrine, Metabolic, and Abnormal Labs9▾

Toxicology and Behavioral14▾

Pediatrics16▾

Environmental and Exposure4▾

01History/hx92

Symptom characterization

›Tremor and involuntary movement profile

›Time of onset

›Abrupt onset

›Gradual onset

›Course

›Progressive

›Fluctuating

›Episodic

›Pattern

›Continuous

›Intermittent

›Body distribution

›Unilateral

›Bilateral

›Focal

›Generalized

›Tremor activation state

›Rest tremor

›Postural tremor

›Action tremor

›Intention tremor

›Movement phenomenology

›Myoclonus

›Chorea

›Dystonia

›Tics

›Asterixis

02Alarm Features/alarm25

Immediate threats

›Time critical escalation triggers

›New focal neurologic deficit with sudden onset

›Altered level of consciousness

›Generalized tonic clonic seizure

›Recurrent seizures without recovery

›Hyperthermia

›Severe rigidity

›Severe agitation

›Autonomic instability

›Severe headache with meningismus

›Severe hypoglycemia

Vital sign danger thresholds

›High risk physiology

›Temperature 38.5 C or higher with rigidity or clonus

›Heart rate 130 or higher with agitation or diaphoresis

›Systolic blood pressure 180 or higher with neurologic symptoms

›Respiratory rate 30 or higher with altered mental status

›Oxygen saturation below 92 percent on room air

High risk exam findings

›High risk neurologic signs

›Hyperreflexia with clonus

›Lead pipe rigidity

›Severe truncal ataxia

›Papilledema

›Meningismus

›Asterixis with encephalopathy

›Severe dysphagia or aspiration risk

03Medications/meds35

Medication exposure review

›Tremor and movement disorder triggers

›Recent medication changes

›Dose increases

›Missed doses

›New interacting medications

›OTC and supplements

High risk medication classes

›Common culprits

›Antipsychotics

›Antiemetics dopamine blockers

›SSRIs and SNRIs

›TCAs

›Lithium

›Valproate

›Stimulants

›Beta agonists

›Theophylline

›Thyroid hormone

›Amiodarone

›Tacrolimus

›Cyclosporine

›Corticosteroids

Withdrawal risk

›Recent cessation

›Alcohol

›Benzodiazepines

›Barbiturates

04Diet/diet12

Stimulants and metabolic contributors

›Dietary and intake patterns

›Caffeine intake

›Energy drink intake

›Recent fasting

›Poor oral intake

›Dehydration

›Recent vomiting

›High sugar intake with reactive symptoms

Alcohol exposure

›Alcohol pattern and timing

›Daily use

›Last drink time

›Prior withdrawal seizures

05Review of Systems/ros28

Neurologic

›Associated neurologic symptoms

›Headache

›Vision changes

›Vertigo

›Gait instability

›Dysarthria

›Dysphagia

›Weakness

›Sensory loss

Psychiatric and autonomic

›Behavioral and autonomic symptoms

›Anxiety

›Panic symptoms

›Akathisia

›Insomnia

›Sweating

›Tremulousness with inner restlessness

Infectious and inflammatory

›Infection indicators

›Fever

›Chills

›Neck pain

›Photophobia

Endocrine and metabolic

›Metabolic symptoms

›Weight loss

›Heat intolerance

06Collateral History and Family History/chafh11

Collateral source

›Source and reliability

›Witness description of events

›Video review availability

›Baseline cognition and function

Family history

›Inherited and familial disorders

›Essential tremor

›Parkinson disease

›Huntington disease

›Wilson disease

›Dystonia

›Epilepsy

07Risk Factors/rf24

Cerebrovascular and neurologic risk

›Stroke and structural lesion risk

›Age over 60

›Hypertension

›Diabetes mellitus

›Atrial fibrillation

›Prior stroke or TIA

›Anticoagulation use

Toxicologic risk

›Exposure risks

›Recreational drug use

›Methamphetamine

›Cocaine

›MDMA

›Cannabis concentrates

›Carbon monoxide exposure

›Heavy metal exposure

Infection and immune risk

›CNS infection risk

›Immunocompromise

›Recent travel

›Recent systemic infection

Special populations

›High consequence groups

›Pregnancy

›Older adults

›Renal failure

›Liver failure

08Differential Diagnosis/ddx79

Life threatening

›Cannot miss etiologies

›Acute ischemic stroke (I63.9)

›Sudden onset focal deficit

›Posterior circulation signs

›Intracerebral hemorrhage (I61.9)

›Severe headache

›Anticoagulation

›Status epilepticus (G40.901)

›Recurrent convulsions

›Persistent altered mental status

›Serotonin syndrome (T43.201A)

›Clonus

›Hyperreflexia

›Hyperthermia

›Neuroleptic malignant syndrome (G21.0)

›Rigidity

›Hyperthermia

›Elevated CK

›Alcohol withdrawal delirium (F10.231)

›Tremor

›Autonomic hyperactivity

›Hallucinations

›Benzodiazepine withdrawal

›Tremor

›Seizure risk

›Hypoglycemia (E16.2)

›Diaphoresis

09Past Medical History/pmh14

Relevant comorbidities

›Conditions influencing differential and management

›Prior stroke or TIA

›Epilepsy

›Parkinson disease diagnosis

›Essential tremor diagnosis

›Thyroid disease

›Chronic liver disease

›Chronic kidney disease

›Psychiatric illness with antipsychotic exposure

Procedures and devices

›Implanted and prior interventions

›Deep brain stimulation

›Cardiac pacemaker

›Recent anesthesia exposure

›Recent medication infusion therapies

10Physical Exam/exam49

General and vitals

›Initial stability and toxidrome screen

›Temperature trend

›Hemodynamic status

›Diaphoresis

›Agitation

›Level of consciousness

Neurologic exam

›Movement focused exam

›Mental status

›Attention

›Orientation

›Cranial nerves

›Nystagmus

›Dysarthria

›Motor

›Tone

›Rigidity

›Strength

›Reflexes

›Hyperreflexia

›Clonus

›Coordination

›Finger nose testing

›Heel shin testing

›Gait

›Ataxia

›Freezing

11Lab Studies/labs33

Core ED labs

›Initial laboratory evaluation

›Point of care glucose

›CBC

›Electrolytes

›Sodium

›Potassium

›Calcium

›Magnesium

›Creatinine and urea

›Liver enzymes

›TSH

Targeted labs by syndrome

›Syndrome directed testing

›Creatine kinase

›Concern for NMS

›Concern for rhabdomyolysis

›Venous blood gas

›Severe agitation

›Hyperthermia

›Ammonia

›Encephalopathy with liver disease

›Asterixis

›Serum and urine toxicology

›Unknown ingestion

›Sympathomimetic toxidrome

›Pregnancy test

›Childbearing potential

12Imaging/img27

Scoring Systems

›Risk tools and when to use

›NIH Stroke Scale

›Focal deficit

›Thrombolysis pathway support

›CIWA Ar

›Alcohol withdrawal severity

›Benzodiazepine dosing guidance

MRI

›MRI brain indications

›Posterior fossa signs

›Subacute progressive neurologic deficits

›Demyelination concern

›MRI considerations

›Implant screening

›Motion artifact risk with severe tremor

›CT head indications

›Sudden onset focal deficit

›New severe headache

›Head trauma

›Anticoagulation

›CT considerations

›Radiation risk

›Contrast allergy history for CTA pathways

Ultrasound

›POCUS adjuncts

›Bladder scan

13Special Tests/spec17

Bedside movement characterization

›Phenomenology support maneuvers

›Spiral drawing

›Handwriting sample

›Finger tapping speed

›Arm outstretched testing

›Wing beating tremor screen

›Asterixis testing

Neuro diagnostic tests

›Advanced testing indications

›EEG

›Myoclonus with altered mental status

›Suspected nonconvulsive seizure

›EMG and nerve conduction studies

›Fasciculations with weakness

›Neuropathy suspicion

›Lumbar puncture

›Fever and meningismus

›Encephalitis concern

14ECG/ecg8

Indications and high risk findings

›ECG in movement presentations

›Tachycardia with hyperadrenergic symptoms

›Electrolyte abnormality concern

›Suspected overdose

›Key patterns

›QT prolongation

›QRS widening

›Atrial fibrillation with rapid ventricular response

15Assessment/ax24

Problem representation

›Working syndrome classification

›Tremor predominant syndrome

›Hyperkinetic movement syndrome

›Hypokinetic parkinsonian syndrome

›Toxidrome mediated syndrome

Severity and risk stratification

›High risk features summary

›Acute onset with focal deficit

›Altered mental status

›Hyperthermia

›Rigidity or clonus

›Recurrent seizures

Leading diagnoses

›Most likely etiologies with supporting features

›Medication induced tremor

›Temporal relation to start or dose change

›Symmetric postural action tremor

›Essential tremor (G25.0)

›Action tremor

›Family history

›Parkinsonism (G20)

›Rest tremor

›Bradykinesia

›Alcohol withdrawal (F10.239)

›Tremor

›Autonomic symptoms

16Plan/plan57

Differential Management

›!Parkinson's Disease (Crisis)→

First 5 minutes

›Immediate stabilization workflow

›Cardiac monitor

›Pulse oximetry

›IV access for unstable patients

›Point of care glucose within 5 minutes

›Temperature measurement within 5 minutes

›If altered mental status

›Escalate to resuscitation bay

›Immediate glucose correction if low

Diagnostic sequencing

›Test and consult pathway

›If focal deficit or sudden onset

›CT head immediately

›Stroke protocol activation per local protocol

›If hyperthermia with clonus or rigidity

›CK

›Electrolytes

›Toxicology review

›If seizure concern

›EEG pathway

›Antiseizure medication per protocol

Therapeutics

›Syndrome directed treatment

›Alcohol withdrawal

›Benzodiazepine dosing per local protocol

17Disposition/dispo20

Level of care

›ICU criteria

›Hyperthermia with rigidity or clonus

›Autonomic instability requiring continuous infusion therapy

›Status epilepticus

›Severe rhabdomyolysis

›Inpatient admission criteria

›New stroke or hemorrhage diagnosis

›Persistent altered mental status

›Moderate to severe withdrawal requiring ongoing sedatives

›Ongoing diagnostic uncertainty with high risk features

Observation pathway

›Observation appropriate features

›Stable vitals after treatment

›Improving symptoms over 4 to 6 hours

›Pending neurology assessment

Discharge criteria

›Safe discharge features

›No alarm features

›Normal neurologic exam or baseline exam documented

›Reversible trigger identified and addressed

›Reliable supervision

›Clear follow up plan within 7 days

18Discharge Instructions/di21

Copy discharge instructions

›Summary

›You were seen for new shaking or involuntary movements

›Your evaluation today did not show an emergency cause that requires admission

›Medicines

›Take medications exactly as prescribed

›Avoid new over the counter stimulants unless discussed with your clinician

›Triggers

›Avoid caffeine and energy drinks for 48 hours

›Prioritize sleep and hydration

›Follow up

›Primary care follow up within 3 to 7 days

›Neurology follow up if symptoms persist or worsen

›Return to emergency care now if

›New weakness

›New trouble speaking

›New severe headache

›Confusion

›Fever

›Stiff muscles

›Fainting

›Seizure

19References/r6

Guidelines and key sources

›Evidence based sources

›American Academy of Neurology practice guidance on tremor and essential tremor 2011

›American College of Emergency Physicians clinical policy on adult seizures in the emergency department 2014

›American Heart Association and American Stroke Association guidelines for early management of acute ischemic stroke 2019

›Neurologic emergency guidance on serotonin syndrome and neuroleptic malignant syndrome review standards 2020

›Society of Critical Care Medicine guidance on management of alcohol withdrawal and delirium in critical illness 2020

Evidence & Review

Reviewed by SymptomDx Medical Team · Last reviewed February 24, 2026

SymptomDx is an educational tool for medical professionals. It does not replace clinical judgment. Verify all clinical data and drug dosages with authoritative sources.

New Tremor and Involuntary MovementsAPPROACH

NEUROLOGIC · 19 SECTIONS

⚲

582 items

☷ Legend

⚲

Resuscitation and Universal Approaches9▾

Chest and Cardiovascular12▾

Respiratory11▾

Abdominal and Gastrointestinal24▾

Renal and Urinary7▾

Neurologic11▾

Back and Neck8▾

Women's Health, Pregnancy, and GU11▾

Infectious Disease and Fever Syndromes11▾

Allergy and Dermatology7▾

Musculoskeletal and Extremities14▾

Trauma and Wounds14▾

ENT, Eye, Dental10▾

Endocrine, Metabolic, and Abnormal Labs9▾

Toxicology and Behavioral14▾

Pediatrics16▾

Environmental and Exposure4▾

01History/hx92

Symptom characterization

›Tremor and involuntary movement profile

›Time of onset

›Abrupt onset

›Gradual onset

›Course

›Progressive

›Fluctuating

›Episodic

›Pattern

›Continuous

›Intermittent

›Body distribution

›Unilateral

›Bilateral

›Focal

›Generalized

›Tremor activation state

›Rest tremor

›Postural tremor

›Action tremor

›Intention tremor

›Movement phenomenology

›Myoclonus

›Chorea

›Dystonia

›Tics

›Asterixis

02Alarm Features/alarm25

Immediate threats

›Time critical escalation triggers

›New focal neurologic deficit with sudden onset

›Altered level of consciousness

›Generalized tonic clonic seizure

›Recurrent seizures without recovery

›Hyperthermia

›Severe rigidity

›Severe agitation

›Autonomic instability

›Severe headache with meningismus

›Severe hypoglycemia

Vital sign danger thresholds

›High risk physiology

›Temperature 38.5 C or higher with rigidity or clonus

›Heart rate 130 or higher with agitation or diaphoresis

›Systolic blood pressure 180 or higher with neurologic symptoms

›Respiratory rate 30 or higher with altered mental status

›Oxygen saturation below 92 percent on room air

High risk exam findings

›High risk neurologic signs

›Hyperreflexia with clonus

›Lead pipe rigidity

›Severe truncal ataxia

›Papilledema

›Meningismus

›Asterixis with encephalopathy

›Severe dysphagia or aspiration risk

03Medications/meds35

Medication exposure review

›Tremor and movement disorder triggers

›Recent medication changes

›Dose increases

›Missed doses

›New interacting medications

›OTC and supplements

High risk medication classes

›Common culprits

›Antipsychotics

›Antiemetics dopamine blockers

›SSRIs and SNRIs

›TCAs

›Lithium

›Valproate

›Stimulants

›Beta agonists

›Theophylline

›Thyroid hormone

›Amiodarone

›Tacrolimus

›Cyclosporine

›Corticosteroids

Withdrawal risk

›Recent cessation

›Alcohol

›Benzodiazepines

›Barbiturates

04Diet/diet12

Stimulants and metabolic contributors

›Dietary and intake patterns

›Caffeine intake

›Energy drink intake

›Recent fasting

›Poor oral intake

›Dehydration

›Recent vomiting

›High sugar intake with reactive symptoms

Alcohol exposure

›Alcohol pattern and timing

›Daily use

›Last drink time

›Prior withdrawal seizures

05Review of Systems/ros28

Neurologic

›Associated neurologic symptoms

›Headache

›Vision changes

›Vertigo

›Gait instability

›Dysarthria

›Dysphagia

›Weakness

›Sensory loss

Psychiatric and autonomic

›Behavioral and autonomic symptoms

›Anxiety

›Panic symptoms

›Akathisia

›Insomnia

›Sweating

›Tremulousness with inner restlessness

Infectious and inflammatory

›Infection indicators

›Fever

›Chills

›Neck pain

›Photophobia

Endocrine and metabolic

›Metabolic symptoms

›Weight loss

›Heat intolerance

06Collateral History and Family History/chafh11

Collateral source

›Source and reliability

›Witness description of events

›Video review availability

›Baseline cognition and function

Family history

›Inherited and familial disorders

›Essential tremor

›Parkinson disease

›Huntington disease

›Wilson disease

›Dystonia

›Epilepsy

07Risk Factors/rf24

Cerebrovascular and neurologic risk

›Stroke and structural lesion risk

›Age over 60

›Hypertension

›Diabetes mellitus

›Atrial fibrillation

›Prior stroke or TIA

›Anticoagulation use

Toxicologic risk

›Exposure risks

›Recreational drug use

›Methamphetamine

›Cocaine

›MDMA

›Cannabis concentrates

›Carbon monoxide exposure

›Heavy metal exposure

Infection and immune risk

›CNS infection risk

›Immunocompromise

›Recent travel

›Recent systemic infection

Special populations

›High consequence groups

›Pregnancy

›Older adults

›Renal failure

›Liver failure

08Differential Diagnosis/ddx79

Life threatening

›Cannot miss etiologies

›Acute ischemic stroke (I63.9)

›Sudden onset focal deficit

›Posterior circulation signs

›Intracerebral hemorrhage (I61.9)

›Severe headache

›Anticoagulation

›Status epilepticus (G40.901)

›Recurrent convulsions

›Persistent altered mental status

›Serotonin syndrome (T43.201A)

›Clonus

›Hyperreflexia

›Hyperthermia

›Neuroleptic malignant syndrome (G21.0)

›Rigidity

›Hyperthermia

›Elevated CK

›Alcohol withdrawal delirium (F10.231)

›Tremor

›Autonomic hyperactivity

›Hallucinations

›Benzodiazepine withdrawal

›Tremor

›Seizure risk

›Hypoglycemia (E16.2)

›Diaphoresis

09Past Medical History/pmh14

Relevant comorbidities

›Conditions influencing differential and management

›Prior stroke or TIA

›Epilepsy

›Parkinson disease diagnosis

›Essential tremor diagnosis

›Thyroid disease

›Chronic liver disease

›Chronic kidney disease

›Psychiatric illness with antipsychotic exposure

Procedures and devices

›Implanted and prior interventions

›Deep brain stimulation

›Cardiac pacemaker

›Recent anesthesia exposure

›Recent medication infusion therapies

10Physical Exam/exam49

General and vitals

›Initial stability and toxidrome screen

›Temperature trend

›Hemodynamic status

›Diaphoresis

›Agitation

›Level of consciousness

Neurologic exam

›Movement focused exam

›Mental status

›Attention

›Orientation

›Cranial nerves

›Nystagmus

›Dysarthria

›Motor

›Tone

›Rigidity

›Strength

›Reflexes

›Hyperreflexia

›Clonus

›Coordination

›Finger nose testing

›Heel shin testing

›Gait

›Ataxia

›Freezing

11Lab Studies/labs33

Core ED labs

›Initial laboratory evaluation

›Point of care glucose

›CBC

›Electrolytes

›Sodium

›Potassium

›Calcium

›Magnesium

›Creatinine and urea

›Liver enzymes

›TSH

Targeted labs by syndrome

›Syndrome directed testing

›Creatine kinase

›Concern for NMS

›Concern for rhabdomyolysis

›Venous blood gas

›Severe agitation

›Hyperthermia

›Ammonia

›Encephalopathy with liver disease

›Asterixis

›Serum and urine toxicology

›Unknown ingestion

›Sympathomimetic toxidrome

›Pregnancy test

›Childbearing potential

12Imaging/img27

Scoring Systems

›Risk tools and when to use

›NIH Stroke Scale

›Focal deficit

›Thrombolysis pathway support

›CIWA Ar

›Alcohol withdrawal severity

›Benzodiazepine dosing guidance

MRI

›MRI brain indications

›Posterior fossa signs

›Subacute progressive neurologic deficits

›Demyelination concern

›MRI considerations

›Implant screening

›Motion artifact risk with severe tremor

›CT head indications

›Sudden onset focal deficit

›New severe headache

›Head trauma

›Anticoagulation

›CT considerations

›Radiation risk

›Contrast allergy history for CTA pathways

Ultrasound

›POCUS adjuncts

›Bladder scan

13Special Tests/spec17

Bedside movement characterization

›Phenomenology support maneuvers

›Spiral drawing

›Handwriting sample

›Finger tapping speed

›Arm outstretched testing

›Wing beating tremor screen

›Asterixis testing

Neuro diagnostic tests

›Advanced testing indications

›EEG

›Myoclonus with altered mental status

›Suspected nonconvulsive seizure

›EMG and nerve conduction studies

›Fasciculations with weakness

›Neuropathy suspicion

›Lumbar puncture

›Fever and meningismus

›Encephalitis concern

14ECG/ecg8

Indications and high risk findings

›ECG in movement presentations

›Tachycardia with hyperadrenergic symptoms

›Electrolyte abnormality concern

›Suspected overdose

›Key patterns

›QT prolongation

›QRS widening

›Atrial fibrillation with rapid ventricular response

15Assessment/ax24

Problem representation

›Working syndrome classification

›Tremor predominant syndrome

›Hyperkinetic movement syndrome

›Hypokinetic parkinsonian syndrome

›Toxidrome mediated syndrome

Severity and risk stratification

›High risk features summary

›Acute onset with focal deficit

›Altered mental status

›Hyperthermia

›Rigidity or clonus

›Recurrent seizures

Leading diagnoses

›Most likely etiologies with supporting features

›Medication induced tremor

›Temporal relation to start or dose change

›Symmetric postural action tremor

›Essential tremor (G25.0)

›Action tremor

›Family history

›Parkinsonism (G20)

›Rest tremor

›Bradykinesia

›Alcohol withdrawal (F10.239)

›Tremor

›Autonomic symptoms

16Plan/plan57

Differential Management

›!Parkinson's Disease (Crisis)→

First 5 minutes

›Immediate stabilization workflow

›Cardiac monitor

›Pulse oximetry

›IV access for unstable patients

›Point of care glucose within 5 minutes

›Temperature measurement within 5 minutes

›If altered mental status

›Escalate to resuscitation bay

›Immediate glucose correction if low

Diagnostic sequencing

›Test and consult pathway

›If focal deficit or sudden onset

›CT head immediately

›Stroke protocol activation per local protocol

›If hyperthermia with clonus or rigidity

›CK

›Electrolytes

›Toxicology review

›If seizure concern

›EEG pathway

›Antiseizure medication per protocol

Therapeutics

›Syndrome directed treatment

›Alcohol withdrawal

›Benzodiazepine dosing per local protocol

17Disposition/dispo20

Level of care

›ICU criteria

›Hyperthermia with rigidity or clonus

›Autonomic instability requiring continuous infusion therapy

›Status epilepticus

›Severe rhabdomyolysis

›Inpatient admission criteria

›New stroke or hemorrhage diagnosis

›Persistent altered mental status

›Moderate to severe withdrawal requiring ongoing sedatives

›Ongoing diagnostic uncertainty with high risk features

Observation pathway

›Observation appropriate features

›Stable vitals after treatment

›Improving symptoms over 4 to 6 hours

›Pending neurology assessment

Discharge criteria

›Safe discharge features

›No alarm features

›Normal neurologic exam or baseline exam documented

›Reversible trigger identified and addressed

›Reliable supervision

›Clear follow up plan within 7 days

18Discharge Instructions/di21

Copy discharge instructions

›Summary

›You were seen for new shaking or involuntary movements

›Your evaluation today did not show an emergency cause that requires admission

›Medicines

›Take medications exactly as prescribed

›Avoid new over the counter stimulants unless discussed with your clinician

›Triggers

›Avoid caffeine and energy drinks for 48 hours

›Prioritize sleep and hydration

›Follow up

›Primary care follow up within 3 to 7 days

›Neurology follow up if symptoms persist or worsen

›Return to emergency care now if

›New weakness

›New trouble speaking

›New severe headache

›Confusion

›Fever

›Stiff muscles

›Fainting

›Seizure

19References/r6

Guidelines and key sources

›Evidence based sources

›American Academy of Neurology practice guidance on tremor and essential tremor 2011

›American College of Emergency Physicians clinical policy on adult seizures in the emergency department 2014

›American Heart Association and American Stroke Association guidelines for early management of acute ischemic stroke 2019

›Neurologic emergency guidance on serotonin syndrome and neuroleptic malignant syndrome review standards 2020

›Society of Critical Care Medicine guidance on management of alcohol withdrawal and delirium in critical illness 2020

Evidence & Review

Reviewed by SymptomDx Medical Team · Last reviewed February 24, 2026

SymptomDx is an educational tool for medical professionals. It does not replace clinical judgment. Verify all clinical data and drug dosages with authoritative sources.